The approval of prolonged-performing cabotegravir injected as soon as each individual two months expands biomedical HIV avoidance selections available to individuals in The usa, providing an alternative choice to daily oral capsules. For those who are interested in becoming our Editorial Board member, remember to post the subsequent facts to https://www.directivepublications.org/journal-of-hiv-aids-research/